Amifampridine Phosphate Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 10 mg
Reference Brands: Firdapse (USA)
Category: Neurology
Amifampridine phosphate is used for the treatment of Lambert-Eaton myasthenic syndrome (LEMS), a rare autoimmune disorder that affects nerve–muscle communication, leading to muscle weakness. It acts by blocking potassium channels and prolonging nerve terminal depolarization, enhancing acetylcholine release at the neuromuscular junction. Amifampridine phosphate is available in Tablets and strengths such as 10 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Amifampridine phosphate is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Amifampridine phosphate can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Amifampridine phosphate is used to treat Lambert-Eaton myasthenic syndrome (LEMS), a rare autoimmune disorder that affects the connection between nerves and muscles, causing muscle weakness. The medication helps improve muscle strength by enhancing the release of acetylcholine at the neuromuscular junction, improving nerve signal transmission to muscles.
Amifampridine phosphate is made from the active ingredient amifampridine phosphate, a potassium channel blocker that prolongs nerve terminal depolarization and increases acetylcholine release. Its chemical name is 3,4-diaminopyridine phosphate. Inactive ingredients may include mannitol, magnesium stearate, and microcrystalline cellulose depending on the formulation.
The trade names of amifampridine phosphate are Firdapse and Amifampridine Phosphate Ruzurgi (for specific regions and indications).
Amifampridine phosphate (Firdapse) is manufactured and marketed by Catalyst Pharmaceuticals in the United States and BioMarin Pharmaceutical in Europe.
The generic name of the drug is amifampridine phosphate.
The brand names of amifampridine phosphate are Firdapse and Ruzurgi.
Amifampridine phosphate is manufactured in the United States by Catalyst Pharmaceuticals and in Europe by BioMarin Pharmaceutical, with distribution across North America, the European Union, and other global markets.
Related Products
Donepezil Hydrochloride
Strength:
5 mg, 10 mg, 23 mg
Form: Tablets
Reference Brands: Aricept (USA/EU)
View Details
Acetazolamide Sodium
Strength:
125 mg, 250 mg, 500 mg,
Form: Tablets/ capsules/ Injectable
Reference Brands: Diamox (USA)
View Details
Rimegepant
Strength:
75 mg
Form: Tablets
Reference Brands: Nurtec ODT (USA), Vydura (EU)
View Details
Pimavanserin
Strength:
17 mg, 34 mg, 51 mg
Form: Tablets
Reference Brands: Nuplazid (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
